Recovery Credible, But Margin Volatility Tested—and Proved Real
Q1 delivered 24% revenue growth but 48% profit collapse due to a gas cost shock in the first 45 days. Management's absorption story and recovery narrative are backed by data, but the street is pricing in execution risk.
₹1,167.9 Cr
+24.4% YoY, +2.8% QoQ
₹20.5 Cr
−47.9% YoY, −48.9% QoQ
4.8%
vs ~7% prior, gas-compressed
₹121 Cr
strong despite profit miss
The gap: +24% revenue, −48% profit
On the surface, Q1 looked unremarkable—a soft quarter in a seasonally weak season, paired with 24% revenue growth. But profit collapsed 48% despite that top-line strength. The earnings call and prior guidance explain: Bansal Wire absorbed a ₹5,000-per-tonne gas cost spike in the first 45 days of Q1, when geopolitical tensions in West Asia pushed industrial gas costs to 1.5× the average in some plants, or even doubled in certain locations. The company chose to absorb this shock for existing customer orders rather than break contracts. The result: a blended Q1 EBITDA of ₹4–4.5 per kg (vs. a normal ₹7–8 per kg), with the first 45 days hitting as low as ₹2 per kg. Management's claim—that margins recovered to ₹7–8 per kg from May 15 onwards on new repriced orders—is supported by the facts: once new orders lock in at higher prices, the cost-plus model protects margins. But the unquantified P&L hit in those first six weeks, estimated at ₹6–7 Cr from inventory valuation alone, is the story the headline numbers mask.
Our gas cost has almost tripled in some plants. In some plants it has increased by almost 100%. Blended, I think, our gas cost has increased by about, let's say, 1.5x on an average.
Claims on the call vs. what holds up
Revenue growth ~25% YoY
Delivered ₹1,167.9 Cr, growth 24.4% YoY, on volume +8.7% QoQ (112k MT) plus price realization
Supported
Back to ₹7–8 ₹/kg EBITDA from May 15 onwards
Blended Q1 confirmed at ₹4–4.5 ₹/kg; first 45 days at ₹2 ₹/kg, rest at ₹7–8 ₹/kg. Trajectory aligns.
Supported
Absorbed ₹5,000/tonne cost spike without passing to customers in first 45 days
PAT down 47.9% YoY, NPM collapsed to 1.8% despite 24.4% revenue growth; confirms deep margin compression
Supported
20% volume and EBITDA growth guidance for rest of FY27 remains on track
Q1 volume +8.7% QoQ on soft demand; capacity 680k tonnes with 20–25% buffer. Demand soft in H1 Q1, improving from May.
Partial—reaffirmed but not raised despite recovery; caution embedded
Operating cash flow ₹121 Cr in seasonally soft quarter
Confirmed at ₹121 Cr; validates working capital discipline and receivable/inventory management
Supported
What changed on this call
Capex guidance raised: From ₹150–200 Cr combined (prior two-year pool) to ₹200–250 Cr annually. Signals confidence despite soft Q1.
Steel Cord trial order secured: First trial from a leading Indian tire manufacturer. Qualification typically 6–8 months; de-risks import substitution thesis.
B2C scaling faster than expected: Now 10% of sales (vs 5–10% guidance), margins 20–30% higher than B2B. Doubled YoY.
Volume guidance maintained, not cut: Despite Q1 demand slowdown and cost shock, reaffirmed 20% growth for rest of FY27.
The debate
The bull-bear ledger
20-year proven track record of 20% annual growth; Volume +8.7% in soft Q1 ahead of typical seasonality
Q1 PAT collapse of 48% despite 24% revenue growth; Cost-plus model lag created unquantified ₹6–7 Cr inventory hit
Strong OCF (₹121 Cr) despite earnings miss; Working capital discipline and inventory hedge 70–80% effective
Capex raised to ₹200–250 Cr/year but EBITDA guidance flat at 20%; Suggests caution despite recovery narrative
Speciality Wire (Steel Cord, IHT) a real catalyst, but still in trials; 6–8 months to commercial orders, 12–18 months to optimum utilization
B2C now 10% of sales with 20–30% margin premium; Doubled YoY, de-risks base wire volatility
Geopolitical and energy cost risk persists; If West Asia unrest continues, gas costs stay 1.5× elevated
Ranked risks—what should concern a holder
Geopolitical risk / energy cost persistence — West Asia tensions; gas prices stay 1.5× average or worse
HighQ1 absorbed ₹5k/tonne without price pass-through; if elevated prices persist, new orders at higher cost and customer pushback risk. 20% EBITDA growth premised on margin recovery to ₹7–8 ₹/kg; if prices stay spiked, that assumption breaks.
Margin volatility and hedging model lag — 30–40 day inventory creates lag; cost-plus model tested and had limits
HighUnquantified ₹6–7 Cr P&L hit from inventory valuation in Q1. If energy/raw material prices spike again and stabilize elevated, next quarter faces similar absorption pressure. Model works in stable or slowly rising markets; sudden shocks expose lag risk.
Demand softness extends beyond Q1 — Customer de-stocking; macro slowdown in auto/infra could persist
Medium20% volume growth assumes demand recovery from June onwards. If macro weakens, de-stocking persists, or auto OEMs delay orders post-trial, volume growth misses despite capacity headroom. No single customer >3–4%, but major tire maker order delay = topline risk.
Speciality ramp slower than plan — Steel Cord trials may extend beyond 6–8 months; IHT/OHT approvals may stall
MediumManagement assumes 2 lakh tonne Speciality capacity by FY30 generating ₹600–800 Cr EBITDA. If trials take 12+ months, utilization ramps to 50–60% instead of 70–80%, revenue contribution misses FY27–FY28. 20% EBITDA growth assumes Speciality contribution; delay = guidance miss.
Capex burn and leverage risk — ₹200–250 Cr per year for 5 years; Speciality ₹2–2.5k Cr capex total
MediumCurrent run-rate EBITDA ~₹250 Cr (Q1 compressed at ₹57 Cr). If demand misses or Speciality ramp slows, cash flow tightens and leverage rises. Capex acceleration + earnings volatility = financing risk if equity unavailable.
Raw material (steel) cost premium — India premium ₹10–15 Cr/kg vs China; Speciality margin sensitive; exports ruled out
MediumManagement cited premium as 50% of Speciality margin; export Speciality ruled out. If global steel prices rise and Indian stay elevated, domestic Speciality margins compress. Mitigated by import substitution, but premium is long-term drag.
How the street is positioned
The market's reaction tells its own story. On day 1 post-result (result announced Wed Jul 22 2026), the stock fell 2.46%—a move that didn't hold conviction. By day 3, it had stabilized (+0.63%), and by day 5 the decline had faded to +0.59%, but momentum remained weak. The stock is now trading at ₹315.45 (as of 2026-07-31), down 14.7% from its all-time high and sitting below both its 20-day (₹323.67) and 50-day (₹319.13) simple moving averages. RSI is 43.4 (neutral), and volume is decreasing—a sign of low conviction either way. The 52-week range of ₹222.5–₹369.8 puts the current level 41.78% above the low but 14.7% below the high, indicating a stock that has lost momentum.
Ownership flows are mixed. Foreign Institutional Investors (FII) have been exiting, down 1.24 percentage points quarter-on-quarter to just 0.88%—the lowest holding in a year. Domestic Institutional Investors (DII) are adding, up 1.39 percentage points to 17.05%, suggesting retail and local funds are accumulating on weakness. Promoters remain steady at 77.99%, a sign of insider confidence.
Bulk and block deals reveal institutional activity. Over the past six months, HDFC Mutual Fund, Invesco Mutual Fund, and BNP Paribas Financial Markets have accumulated stakes at ₹309 per share—a price ~1.7% below the current level, suggesting these funds see value. However, a large selling block by Mrinaal Mittal (46.82 lakh shares at ₹309) is notable; selling by substantial shareholders near prior highs (the all-time high was ₹369.8) warrants attention as a signal of caution.
In aggregate, the street is pricing in execution risk. The day-1 decline and failure to recover suggest investors are unconvinced by the recovery narrative or believe margin volatility and Speciality ramp execution risk warrant a valuation discount. FII exit + decreasing volume + below key moving averages = a stock that has lost institutional confidence post-Q1, even if the fundamental story remains intact.
What to watch next
1 · Steel Cord trial completion and commercial order timeline
Management expects 6–8 months per trial stage (currently in stage 1) and multiple tire manufacturer trials this quarter. Track trial completions and progression to commercial orders. If any trial completes faster than 6 months or commercial orders land, Speciality ramp accelerates. Delays extend revenue contribution to FY28, a key miss risk.
2 · IHT/OHT utilization ramp to 50% and beyond
Management targets 50% utilization next month (from current 35–40%) and 70–80% by H2 FY27. Monitor quarterly updates on capacity ramp and per-tonne EBITDA (claimed ₹10–20 ₹/kg). Each 10% utilization gain de-risks the Speciality thesis; stalls suggest customer approvals or product-market fit issues.
3 · Gas and energy cost normalization
The unspoken catalyst. Q1 absorbed cost due to geopolitical shock; recovery narrative assumes prices stabilize. Track global gas/energy indices and management commentary in Q2 calls. If prices normalize, base wire margins revert to ₹7–8 ₹/kg and 20% EBITDA growth is achievable. Persistence of elevated costs will test the cost-plus model again.
4 · Q2 demand recovery and volume trajectory
Management reiterates 20% volume growth for rest of FY27, assuming demand recovery from June onwards. Q2 results will show whether recovery is real or demand remains soft. Look for volume growth QoQ and order book commentary. If Q2 volume +15% or higher, guidance confidence rises; if soft, the 20% target becomes at risk.
The single number to track from here
Bansal Wire is not a broken story; it's a resilience story on test. The company has a proven playbook, sufficient capacity, and real growth drivers in Speciality and B2C. Q1 was genuine shock—margin hit from energy cost spikes that the hedging model couldn't fully buffer. But management absorbed the cost, recovered from May, and reaffirmed guidance rather than cutting it. The street is skeptical, as shown by a 14.7% drawdown from all-time high, FII exit, and weak post-result price action. The skepticism is justified—execution risk is real, Speciality is unproven at scale, and margin volatility is now proven.
What matters from here is not headline EBITDA or revenue guidance, but organic EBITDA recovery to ₹7–8 ₹/kg and sustained retention of that margin as new orders flow through. If Q2 and Q3 show blended EBITDA at ₹6–7 ₹/kg or higher (up from Q1's ₹4–4.5 ₹/kg), the recovery thesis holds and guidance becomes credible. If margins remain compressed below ₹6 ₹/kg due to persistent energy cost pressure, the 20% growth target is at risk and a reset is likely. Volume growth and Speciality trials are secondary—they follow execution, not lead it. For a holder, this is steady execution, not a step-change; the margin recovery is the key.
Informational and educational content only. Not investment advice.